Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice - Test2 - elhamkhani - TriplyDB

Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice

Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice

http://www.wikidata.org/entity/Q24530682

about

Gene Prioritization for Imaging Genetics Studies Using Gene Ontology and a Stratified False Discovery Rate Approach Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease Upregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration Metals and amyloid-beta in Alzheimer's disease TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease Fishy business: effect of omega-3 fatty acids on zinc transporters and free zinc availability in human neuronal cells Gender Dependent Evaluation of Autism like Behavior in Mice Exposed to Prenatal Zinc Deficiency Structure of the zinc transporter YiiP The effect of zinc and the role of p53 in copper-induced cellular stress responses.Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification.Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein.Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.SLC30A3 responds to glucose- and zinc variations in beta-cells and is critical for insulin production and in vivo glucose-metabolism during beta-cell stress.Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology.TRPM7 activates m-calpain by stress-dependent stimulation of p38 MAPK and c-Jun N-terminal kinase.In vivo reduction of amyloid-beta by a mutant copper transporter Zinc overload enhances APP cleavage and Aβ deposition in the Alzheimer mouse brain Endogenous zinc in neurological diseases.Perinatal omega-3 polyunsaturated fatty acid supply modifies brain zinc homeostasis during adulthood Transgenic models of Alzheimer's disease: learning from animals Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice.Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.Zn2+ efflux through lysosomal exocytosis prevents Zn2+-induced toxicity.Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD Zn(II)-coordination modulated ligand photophysical processes - the development of fluorescent indicators for imaging biological Zn(II) ions Phosphorescent sensor for biological mobile zinc.The galvanization of beta-amyloid in Alzheimer's disease.Metal imaging in neurodegenerative diseases.Animal models of amyloid-beta-related pathologies in Alzheimer's disease.Meeting of the minds: metalloneurochemistry Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.Zinc and human health: an update.Biological consequences of zinc deficiency in the pathomechanisms of selected diseases.Metal chaperones: a holistic approach to the treatment of Alzheimer's disease Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition.Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: II. Role of human ZIP9 in testosterone-induced prostate and breast cancer cell apoptosis.

P2860

Q24273353-0E985747-0C8D-4379-83B7-416295AC24D3 Q24298553-F9807188-2C8D-4F86-97A6-018C20DA70FC Q24613053-731A0245-61A5-461D-8EBF-8EB1B187BCFF Q24643555-18349912-EEAE-4083-80EC-818672934692 Q24644588-39ABE714-EAE8-4B87-A3BE-B7240E2DF6DF Q24649556-A316CF7A-B111-453A-BE74-86A202E89FF7 Q26799258-CBCF5B83-41D0-419F-9554-C30096371FF1 Q26999257-9E85E428-4323-427B-921E-090EA1E95C3C Q27321409-3702BFC8-A2C5-4D06-AC56-182561710054 Q27647503-87504553-1EAB-4466-915E-57F9A42F4E8F Q30427092-6BD671BC-C782-42BD-9335-B97BC60ABD5D Q30485664-C3E0A785-142B-4D0C-A8AB-CC3F841B86B4 Q31047131-86CE64E9-2AFD-47B7-8CAE-D0CE73F02FBA Q31128115-49DDB10A-01F2-44A1-B3C6-E9CCEAE2AAA6 Q33320694-4DDF6470-D222-41C5-B1E0-314DCF8D435D Q33459222-933C00A9-4CB2-44FA-B867-F549300A5869 Q33614523-9BC78179-BC18-4215-BE5F-978D54B5AC9F Q33646882-1E46FC30-9602-4D7F-AD7B-DE107CDD7B41 Q33671527-7AC27866-027B-4FE9-B150-5DA3488D9C42 Q33715870-45D59D03-4C18-48F6-821D-E256C9D817F8 Q33778362-02CE3872-53B5-48B1-9B6D-72CA5ADD54B6 Q33790610-4006E719-19D4-4651-AC08-0AECB88998FE Q33821703-2ACD1053-4430-4652-BBAC-E26FE935B339 Q33844718-A13C649A-0748-45DD-94DE-E36445E62DBE Q33851275-CB507A8F-4379-436B-A93E-F07FDEEFCA88 Q33893017-54913932-61DF-4E3D-982B-2E37CB6571CC Q33893336-4AAD47C3-9AA5-4579-A8CE-C1AE722E6A96 Q33894308-861B4821-1D95-4B6A-96D3-0115B09BD02D Q33951488-FA8C2A5C-9448-4448-AF94-04C345AD1A8B Q34056487-BFE2F2AD-DAAC-4DB8-AB16-D978AB499C1C Q34063386-5985B28B-3E2B-4202-8480-1772B63B7BDE Q34073566-0A7D7E62-61BB-465E-B1CF-AD9E6859DF20 Q34097190-4FF72516-A488-4A0C-A79E-FF2C03184F80 Q34185781-49AFCBF3-9409-4B8F-BF99-4D43D163955A Q34189447-096ECE70-47CF-448C-A8EF-3295A90A60AA Q34231267-92FC76F7-C53A-4FCB-9D03-D10CBE332A91 Q34243472-8BB77A13-F505-4096-93B0-BDA8B523D286 Q34260002-816382E1-C12F-41C3-AB21-ACC4328A512F Q34297011-5C3B66CA-3717-4D3E-BAA2-ADABF75C6140 Q34343075-EBB98B79-3DF5-4E19-8E48-402FF0CB9C67

P2860

Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice

http://www.wikidata.org/entity/Q24530682

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@ast

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@en

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@en-gb

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@nl

type

label

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@ast

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@en

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@en-gb

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@nl

prefLabel

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@ast

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@en

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@en-gb

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@nl

P1433

Q24530682-88C02640-933D-445F-AC49-2937E75E26DB

P1476

Q24530682-5D392404-D236-400E-B454-2162220D366F

P2093

Q24530682-08F91E9F-EFE9-487C-916D-FBF9398F9FB3

Q24530682-0ABA7E07-DE6E-4D2A-A60C-A47A3232C956

Q24530682-369E5FE1-1C88-40B5-BE53-0E781FBECB09

Q24530682-C77A3BC2-ED2F-45AB-AA98-CFD51BF159BC

Q24530682-E946DCD7-52E0-4CD5-9B37-795A80A18122

P2860

Q24530682-053D6E0D-98E7-46C7-A9A7-0840853D5BB3

Q24530682-0724A260-29B4-4440-AF5A-61C149E038D9

Q24530682-0BDB5382-2138-4552-A9D6-D0C9017D4DDE

Q24530682-1737B789-8959-4FF9-A8B2-100CFDA2B88C

Q24530682-2C906FD9-7EE8-401D-B55B-F69A5EFBC760

Q24530682-2FEBA98A-8CA6-483B-9D5F-49621DEF1314

Q24530682-4034537F-66CC-48EA-AC78-EF4725448E2C

Q24530682-4039F739-C719-487B-9861-846EEEB97879

Q24530682-4748AD98-F47A-46A0-9F6E-201D14F0524B

Q24530682-48BD7AF3-9674-4F69-81B3-699E3EA93083

P304

Q24530682-F3955965-D2CD-482F-A973-D4D178D235D6

P31

Q24530682-3DE983A2-FBF6-44D1-8694-11742F82BE81

P3181

Q24530682-AD5CDFCB-3B87-4CD1-9653-6C34D98A0BC2

P356

Q24530682-312B6F3B-CF01-4830-88F3-FB448558E615

P407

Q24530682-38D8579E-BC6B-4E8B-A332-EB3C3025D38F

P433

Q24530682-BE7F09F8-31EF-47FC-87B5-A75B74ACA034

P478

Q24530682-1F5A9821-2A69-4C91-A851-7264E46903DF

P577

Q24530682-5C2C8DEC-33BF-4D06-AA3D-CA836A1EDAA5

P5875

Q24530682-DEDDFA7B-73DF-47D0-99F0-21CF16BB6816

P698

Q24530682-2775D83F-2B73-4C2B-BDC7-1D4333F7722B

P921

Q24530682-EA16317F-6D06-45D7-B112-2883853B96F2

P932

Q24530682-4CAAD32D-C384-4DDC-8115-A83BDCB6A839

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Contribution by synaptic zinc ...... ish mutant APP transgenic mice

@en

P2093

Jae-Young Koh

http://www.w3.org/2001/XMLSchema#string

Joo-Yong Lee

http://www.w3.org/2001/XMLSchema#string

Richard D Palmiter

http://www.w3.org/2001/XMLSchema#string

Sang Won Suh

http://www.w3.org/2001/XMLSchema#string

Toby B Cole

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene

Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains

The biochemical basis of zinc physiology

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

P304

7705-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

810883

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.092034699

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11340855

http://www.w3.org/2001/XMLSchema#string

P698

12032347

http://www.w3.org/2001/XMLSchema#string

P921

P932

124328

http://www.w3.org/2001/XMLSchema#string